Oncotarget

Research Papers:

Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia

Cosimo De Nunzio _, Simona Giglio, Antonella Stoppacciaro, Mauro Gacci, Roberto Cirombella, Emidio Luciani, Andrea Tubaro and Andrea Vecchione

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:50904-50910. https://doi.org/10.18632/oncotarget.15144

Metrics: HTML 1164 views  |   ?  


Abstract

Cosimo De Nunzio1, Simona Giglio2, Antonella Stoppacciaro2, Mauro Gacci4, Roberto Cirombella2, Emidio Luciani2, Andrea Tubaro1 and Andrea Vecchione2,3

1Urology Units, Department of Clinical and Molecular Medicine, Ospedale Sant’Andrea, Sapienza University, Rome, Italy

2Surgical Pathology Units, Department of Clinical and Molecular Medicine, Ospedale Sant’Andrea, Sapienza University, Rome, Italy

3Department of Cancer Biology and Genetics/CCC, The Ohio State University, Columbus, OH, USA

4Department of Urology, Careggi Hospital, Firenze, Italy

Correspondence to:

Cosimo De Nunzio, email: cosimodenunzio@virgilio.it

Keywords: autophagy, BPH, LUTS, inflammation, prostate

Received: December 02, 2016     Accepted: January 11, 2017     Published: February 07, 2017

ABSTRACT

Autophagy is a conserved evolutionary process that allows cells to maintain macromolecular synthesis and energy homeostasis during starvation and stressful conditions. We prospectively evaluated the relationship between autophagy and prostatic inflammation in a series of transurethral prostatic resection samples. Inflammatory infiltrates were defined according to the standardized classification of chronic prostatitis of the National Institute of Health. The inflammatory score (IS score) was calculated. High IS score was defined as ≥7. Each sample was stained for anti-LC3B and for anti-P62/SQSTM1 and scored. High p62 or LC3B percentage was defined as >25%, whereas low was defined as <25% of cells with dots.

We analyzed 94 specimens. Overall, 18/94 (19%) showed no sign of prostatic inflammation, whereas 76/94 (81%) presented inflammatory infiltrates. Inflammation was mild in 61/76 (80%), moderate/severe in 15/76 (20%). Patients with high p62 percentage were 62/94 (66%) while 32 (34%) showed low p62 percentage. Patients with high LC3B percentage were 37/94 (39%) while 57(61%) showed low LC3B percentage. Overall 42/94 (44%) patients presented a high p62 percentage and concomitant a low LC3B percentage. IS score was significantly higher in patients with a with high p62 percentage (median IS 7 (6/8) vs 5 (3/7); p= 0.04) and in patients with a low LC3B percentage (median IS 7 (6/8) vs 5 (3/7); p= 0.004) when compared to patients with a low p62 percentage or a high LC3B percentage respectively. On multivariate analysis, p62 (OR: 10.1, 95%CI: 2.6-38.6; p= 0,001) and LC3B expression (OR: 0.319; 95%CI: 0.112-0.907; p= 0.032) were independent predictors of a high IS.

Here we present the first evidence of autophagy deregulation in prostatic inflammation. These results raise many questions about the mechanisms mediating the autophagy dysfunction and the links to prostatic inflammation that need to be addressed.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15144